Allergic diseases and asthma are rapidly growing health problems worldwide with a marked socio-economic impact. Alongside rapid environmental and lifestyle changes, the fast-evolving economies in Asia-Pacific face an increasing burden of allergic diseases. Advances in science, epidemiology, epigenetics, innovation, and technology continually challenge countries in the post-pandemic world. The Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) together with the Malaysian Society of Allergy and Immunology (MSAI) will host the APAAACI 2024 Congress from the 12th – 15th December 2024 in Kuala Lumpur, Malaysia.
The scientific program is being developed as a well-woven combination of cutting edge advances and practical clinical aspects in allergy, asthma, and clinical immunology, addressing the needs of both clinicians and researchers across specialties working in this space. With key international, regional, and national opinion leaders, this will be a truly unique platform for leaders, colleagues, and junior members to share knowledge, network, and interact for the best scientific exchange and future collaborations. We hope the Congress will provide a unique platform as a knowledge base in the treatment and prevention of Allergies, Asthma, and Immunologic Disease.
On behalf of the APAAACI and MSAI, we welcome our industry partners to be part of this Congress. Your support will play an integral part in making the Congress a scientifically rewarding event for all those who participate. Together we can make a difference to the community at large.
Let’s make the APAAACI 2024 Congress a success! We look forward to your active participation!